Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. blood circulation
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Blood Circulation Articles & Analysis

33 news found

Tethis S.p.A. Collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage Breast Cancer

Tethis S.p.A. Collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage Breast Cancer

As part of the collaboration, Tethis has placed one of its automated See.d instruments in the Cristofanilli lab, and the lab will use the instrument to isolate plasma and prepare cytology slides containing cells, including circulating tumor cells, from the blood. The Cristofanilli lab will analyze the isolated plasma samples for cell-free DNA (cfDNA), while ...

ByTethis S.p.A


SOPHiA Genetics and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

SOPHiA Genetics and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

The testing works by isolating cell-free DNA (cfDNA) from blood plasma to uncover circulating tumor DNA (ctDNA). Isolating these DNA samples from a simple blood draw is less invasive than a traditional biopsy, helping to simplify patient monitoring and more quickly guide clinical decision-making. ...

BySOPHiA Genetics


SOPHiA Genetics Announces It Joins the European Liquid Biopsy Society at ECP 2024

SOPHiA Genetics Announces It Joins the European Liquid Biopsy Society at ECP 2024

Liquid biopsy testing offers an alternative to solid tumor testing by isolating cell-free DNA (cfDNA) from blood plasma, which may uncover circulating tumor DNA (ctDNA). This non-invasive testing allows for cancer genomic profiling and disease monitoring. ...

BySOPHiA Genetics


Rarecells, Inc. announces successful Series A funding, reaching $13 Million raised to develop Liquid Biopsy Early Cancer Detection Tests

Rarecells, Inc. announces successful Series A funding, reaching $13 Million raised to develop Liquid Biopsy Early Cancer Detection Tests

Rarecells leverages its proprietary ISET® Circulating Tumor Cells (CTC) platform, combined with cutting-edge downstream analyses, to generate a novel and powerful approach to detect evidence of a tumor from a blood sample. ...

ByRarecells Diagnostics SAS


980nm diode laser for vascular removal

980nm diode laser for vascular removal

It can thermally coagulate hemoglobin in dilated capillaries and endothelial cells in capillaries within milliseconds, thereby sealing the dilated blood vessels immediately. Treatment Features 1. 980nm laser can promote collagen production, improve skin elasticity, and increase skin thickness and density. 2. 980nm laser repairs capillaries, restores the elasticity of capillaries, ...

ByBvlaser Bestview Medical and Beauty Equipment Co., Ltd


FDA clears Sonavex’s ultrasound blood flow monitor

FDA clears Sonavex’s ultrasound blood flow monitor

A complication of microvascular surgery—used to reattach severed body parts such as fingers and hands by reconnecting tiny blood vessels and restoring circulation—is necrosis as a result of reduced blood flow and oxygen. The EchoSure device is designed to detect changes in blood flow to identify problems early. ...

BySonavex, Inc.


CD Formulation Offers Customized Synthesis to Meet the Demand for Lipid Excipients in Drug Discovery

CD Formulation Offers Customized Synthesis to Meet the Demand for Lipid Excipients in Drug Discovery

Some Key Benefits of Lipid Excipients Dissolve drug in the formulation Keep the drug dissolved in the gastrointestinal tract Enhance the absorption of drugs and promote the penetration of drugs through intestinal epithelial cells Long-chain lipid excipients such as carbon chain 212 can promote drugs to enter the blood through lymphatic circulation ...

ByCD Formulation


Study Demonstrates Importance and Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Assessment of Heart Failure

Study Demonstrates Importance and Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Assessment of Heart Failure

The study titled, “Discordance of Pressure and Volume: Potential Implications for Pressure-Guided Remote Monitoring in Heart Failure,” sought to test the relationship (or lack thereof) between a commercially available implantable pulmonary artery pressure (PAP) monitor, estimates of cardiac blood volume, and actual circulating blood ...

ByDaxor Corporation


Classification and Biological Functions of Glycoproteins

Classification and Biological Functions of Glycoproteins

Furthermore, the glycoproteins and glycolipids on the cell surface can be "shed" to the surrounding environment or enter the blood circulation, which can be used as abnormal markers to provide information for clinical diagnosis. ...

ByCreative Proteomics


Leonhardt’s Launchpads Accelerator to Showcase Eight Innovation Assets and Startups At 2022 Demo Day

Leonhardt’s Launchpads Accelerator to Showcase Eight Innovation Assets and Startups At 2022 Demo Day

The 2021 class of Leonhardt’s Launchpads Accelerator graduates include: MyoStim ED with ErectiStimTM: MyoStim ED is the first intervention for erectile dysfunction (ED) designed to address all major causes of ED: impaired blood flow, damaged blood vessels, nerve damage, and muscle deterioration. MyoStim ED utilizes non-invasive bioelectric stimulation ...

BySecond Heart Assist, Inc.


OncoDNA provides strategic support in Radiomics` prospective clinical trial SALMON

OncoDNA provides strategic support in Radiomics` prospective clinical trial SALMON

While Radiomics will lead the radiological characterization of the cases included in the SALMON study through its proprietary advanced technology based on the extraction of quantitative information from DICOM scans, OncoDNA will generate comprehensive OncoKDM reports for the biological characterization and genetic sequencing of NSCLC patients via tissue and liquid biopsy, aimed at the analysis of ...

ByOncoDNA S.A.


FDA Grants the Hemolung® De Novo Clearance

FDA Grants the Hemolung® De Novo Clearance

The Hemolung is indicated for respiratory support that provides extracorporeal carbon dioxide (CO2) removal from the patient’s blood for up to 5 days in adults with acute, reversible respiratory failure for whom ventilation of CO2 cannot be adequately or safely achieved using other available treatment options and continued clinical deterioration is expected. ...

ByLivaNova PLC


Circulating atypical cells detected in blood of lung cancer patients

Circulating atypical cells detected in blood of lung cancer patients

New study data presented at the European Congress of Cytology – held from 3-6 Oct in Warsaw, Poland – confirmed that X-ZELL is able to detect tumour-associated circulating atypical cells in the blood of lung cancer patients The dataset comprised interim results from a pilot study carried out in Thailand by X-ZELL and Dr Kittipong Maneechotesuwan ...

ByX-Zell Inc.


Gyroscope Therapeutics Announces Presentation of Positive Interim Phase I/II Data for Investigational Gene Therapy GT005 at Retina Society Annual Scientific Meeting

Gyroscope Therapeutics Announces Presentation of Positive Interim Phase I/II Data for Investigational Gene Therapy GT005 at Retina Society Annual Scientific Meeting

A new analysis showed no increases in systemic CFI levels circulating in the blood, suggesting GT005’s effects remain localised to the eye as intended. ...

ByNovartis International AG


X-ZELL hMX technology now available for research use

X-ZELL hMX technology now available for research use

Previously exclusive to X-ZELL, the patented system is part of the company’s single-cell diagnostics platform, which is capable of isolating and visualising individual atypical cells from a small 10mL blood sample. According to X-ZELL’s Head of Engineering & Product Development, Sven Strache, the technology is crucial to the routine discovery of next-generation ...

ByX-Zell Inc.


Bastiaan van der Baan and Miro Venturi join Tethis as Independent Members of the Board of Directors

Bastiaan van der Baan and Miro Venturi join Tethis as Independent Members of the Board of Directors

The way they are approaching the largely unaddressed issue of blood sample preparation is really unique and very well structured for future clinical applications. ...

ByTethis S.p.A


Qualigen Therapeutics, Inc. Announces Submission of Investigational New Drug (IND) Application for QN-165, for the Treatment of COVID-19

Qualigen Therapeutics, Inc. Announces Submission of Investigational New Drug (IND) Application for QN-165, for the Treatment of COVID-19

QN-247 (formerly referred to as ALAN) is a DNA coated gold nanoparticle cancer drug candidate that has the potential to target various types of cancer with minimal side effects; the nanoparticle coating technology is similar to the core nanoparticle coating technology used in our blood-testing diagnostic products. The foundational aptamer of QN-247, QN-165, is also a drug ...

ByQualigen Therapeutics, Inc.


Meissa Vaccines Begins Study of RSV Vaccine Candidate in Seronegative Children

Meissa Vaccines Begins Study of RSV Vaccine Candidate in Seronegative Children

Intranasal vaccines generate both serum (IgG) antibodies that circulate in the blood and mucosal (IgA) antibodies in the nasal cavity. ...

ByMeissa Vaccines, Inc.


Creative Enzymes Launches DSPE-PEG-Maleimide for Targeted Drug Delivery

Creative Enzymes Launches DSPE-PEG-Maleimide for Targeted Drug Delivery

It is often used in targeted drug delivery with the lipid bilayer to improve drug solubility, the PEG to provide stealth property, extend circulation half-life and reduce non-specific protein binding or cell adhesion, and the reactive maleimide to bioconjugate targeting molecules including antibody, aptamer, protein, and peptide. ...

ByCreative Enzymes


Philip Morris International and TissUse develop a human aerosol test platform to emulate the entire human respiratory tract

Philip Morris International and TissUse develop a human aerosol test platform to emulate the entire human respiratory tract

The novel integrated HUMIMIC–InHALES test platform will allow acute and subchronic tests on lung models in combination with miniaturized human liver equivalents, enabling assessment of local effects on the biological barrier of lung epithelia, penetration of substances into blood circulation, and eventual systemic effects. Altogether, HUMIMIC–InHALES ...

ByTissUse GmbH

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT